These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19057930)

  • 1. Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites.
    Berchanski A; Lapidot A
    J Mol Model; 2009 Mar; 15(3):281-94. PubMed ID: 19057930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step.
    Borkow G; Vijayabaskar V; Lara HH; Kalinkovich A; Lapidot A
    Antiviral Res; 2003 Nov; 60(3):181-92. PubMed ID: 14638394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of HIV-1 entry inhibitors neomycin-arginine conjugates interaction with the CD4-gp120 binding site by molecular modeling and multistep docking procedure.
    Berchanski A; Lapidot A
    Biochim Biophys Acta; 2007 Sep; 1768(9):2107-19. PubMed ID: 17560540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
    Hegde R; Borkow G; Berchanski A; Lapidot A
    FEBS J; 2007 Dec; 274(24):6523-36. PubMed ID: 18028446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NeoR6 inhibits HIV-1-CXCR4 interaction without affecting CXCL12 chemotaxis activity.
    Lapidot A; Peled A; Berchanski A; Pal B; Kollet O; Lapidot T; Borkow G
    Biochim Biophys Acta; 2008 Jun; 1780(6):914-20. PubMed ID: 18410746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HIV-1 peptide derivatives based on the HIV-1 Co-receptor CXCR4.
    Hashimoto C; Nomura W; Narumi T; Fujino M; Tsutsumi H; Haseyama M; Yamamoto N; Murakami T; Tamamura H
    ChemMedChem; 2013 Oct; 8(10):1668-72. PubMed ID: 24039179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into the mechanisms of aminoglycoside derivatives interaction with HIV-1 entry steps and viral gene transcription.
    Lapidot A; Berchanski A; Borkow G
    FEBS J; 2008 Nov; 275(21):5236-57. PubMed ID: 18803669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection.
    Cabrera C; Gutiérrez A; Blanco J; Barretina J; Litovchick A; Lapidot A; Evdokimov AG; Clotet B; Esté JA
    AIDS Res Hum Retroviruses; 2000 May; 16(7):627-34. PubMed ID: 10791873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection.
    Klasse PJ; Rosenkilde MM; Signoret N; Pelchen-Matthews A; Schwartz TW; Marsh M
    J Virol; 1999 Sep; 73(9):7453-66. PubMed ID: 10438835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities.
    Brelot A; Heveker N; Montes M; Alizon M
    J Biol Chem; 2000 Aug; 275(31):23736-44. PubMed ID: 10825158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in gp41 and gp120 of HIV-1 isolates resistant to hexa-arginine neomycin B conjugate.
    Borkow G; Lara HH; Lapidot A
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1047-52. PubMed ID: 14651977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand selectivity of a synthetic CXCR4 mimetic peptide.
    Groß A; Brox R; Damm D; Tschammer N; Schmidt B; Eichler J
    Bioorg Med Chem; 2015 Jul; 23(14):4050-5. PubMed ID: 25801155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
    Mbemba E; Benjouad A; Saffar L; Gattegno L
    Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
    Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
    J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
    Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
    J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel peptides based on HIV-1 gp120 sequence with homology to chemokines inhibit HIV infection in cell culture.
    Chertov O; Zhang N; Chen X; Oppenheim JJ; Lubkowski J; McGrath C; Sowder RC; Crise BJ; Malyguine A; Kutzler MA; Steele AD; Henderson EE; Rogers TJ
    PLoS One; 2011 Jan; 6(1):e14474. PubMed ID: 21264298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.
    Connell BJ; Baleux F; Coic YM; Clayette P; Bonnaffé D; Lortat-Jacob H
    Chem Biol; 2012 Jan; 19(1):131-9. PubMed ID: 22284360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
    Hamza A; Zhan CG
    J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains.
    Tian S; Choi WT; Liu D; Pesavento J; Wang Y; An J; Sodroski JG; Huang Z
    J Virol; 2005 Oct; 79(20):12667-73. PubMed ID: 16188969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.
    Pacheco B; Alsahafi N; Debbeche O; Prévost J; Ding S; Chapleau JP; Herschhorn A; Madani N; Princiotto A; Melillo B; Gu C; Zeng X; Mao Y; Smith AB; Sodroski J; Finzi A
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28003492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.